Profile | GDS2987 / GI_31563516-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 3.3 | 12 |
GSM215244 | HMVEC_vehicle_rep2 | 5.4 | 14 |
GSM215253 | HMVEC_vehicle_rep3 | 11.8 | 37 |
GSM215254 | HMVEC_atorvastatin_rep1 | 19.6 | 46 |
GSM215282 | HMVEC_atorvastatin_rep3 | ||
GSM215344 | HMVEC_atorvastatin_rep2 | 0.3 | 1 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | ||
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 8.1 | 17 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 27 | 41 |
GSM215294 | HMVEC_SLx2119_rep1 | 17.2 | 51 |
GSM215295 | HMVEC_SLx2119_rep2 | 7.8 | 16 |
GSM215296 | HMVEC_SLx2119_rep3 | ||
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | 24.9 | 37 |
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | 33.4 | 47 |
GSM215313 | PASMC_atorvastatin_rep3 | 11.5 | 18 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 45.3 | 58 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 9.9 | 20 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 11.2 | 19 |
GSM215327 | PASMC_SLx2119_rep1 | 16.9 | 29 |
GSM215328 | PASMC_SLx2119_rep2 | 1 | 2 |
GSM215329 | PASMC_SLx2119_rep3 | 16.8 | 31 |
GSM215330 | Fibroblasts_vehicle_rep1 | 18 | 39 |
GSM215331 | Fibroblasts_vehicle_rep2 | 11.2 | 31 |
GSM215332 | Fibroblasts_vehicle_rep3 | 19.8 | 52 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 5.5 | 15 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 23.7 | 53 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 8.1 | 21 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 19.8 | 53 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 18.1 | 49 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 37.8 | 64 |
GSM215339 | Fibroblasts_SLx2119_rep1 | ||
GSM215340 | Fibroblasts_SLx2119_rep2 | 17.1 | 43 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 1.1 | 3 |